MedPath

Merz Aesthetics GmbH

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

A Study of NT 201 Doses in the Treatment of Platysma Prominence

Phase 2
Completed
Conditions
Platysma Prominence
Interventions
Drug: NT 201 Placebo
First Posted Date
2023-03-17
Last Posted Date
2024-10-21
Lead Sponsor
Merz Aesthetics GmbH
Target Recruit Count
73
Registration Number
NCT05773053
Locations
🇺🇸

Merz Investigation Site #0010170, Washington, District of Columbia, United States

🇺🇸

Merz Investigational Site #0010453, Aventura, Florida, United States

🇺🇸

Merz Investigation Site #0010470, Coral Gables, Florida, United States

and more 4 locations

Investigation of the Effectiveness and Safety of MRZF111 in the Treatment of Décolleté Wrinkles

Not Applicable
Completed
Conditions
Décolleté Wrinkles
Interventions
Device: MRZF111
First Posted Date
2019-11-26
Last Posted Date
2023-12-26
Lead Sponsor
Merz Aesthetics GmbH
Target Recruit Count
117
Registration Number
NCT04177212
Locations
🇩🇪

Merz Investigational Site #0490189, Bad Soden, Germany

🇩🇪

Merz Investigational Site #0490375, Drensteinfurt, Germany

🇩🇪

Merz Investigational Site #0490095, Hamburg, Germany

and more 6 locations

Study to Investigate the Safety and Duration of Effect of Different Botulinum Toxin A (NT 201) Dose Groups Following the Treatment of Glabellar Frown Lines

Phase 2
Completed
Conditions
Moderate to Severe Glabellar Frown Lines
Interventions
First Posted Date
2019-01-16
Last Posted Date
2023-11-15
Lead Sponsor
Merz Aesthetics GmbH
Target Recruit Count
241
Registration Number
NCT03806933
Locations
🇺🇸

Clinical Testing of Beverly Hills, Merz Investigational Site #0010395, Encino, California, United States

🇺🇸

Medical Associates Inc., Merz Investigational Site #0010435, Newport Beach, California, United States

🇺🇸

Cosmetic Laser Dermatology, Merz Investigational Site #0010321, San Diego, California, United States

and more 6 locations
© Copyright 2025. All Rights Reserved by MedPath